|
1
|
Sawair F, Hassona Y, Irwin C, Stephenson
M, Hamilton P, Maxwell P, Gordon D, Leonard A and Napier S: p53,
Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) expression at invasive
tumour fronts of oral squamous cell carcinomas and development of
local recurrence. Asian Pac J Cancer Prev. 17:1243–1249. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi BB and Shu KS: Metaplastic carcinoma
of the breast: Multimodality imaging and histopathologic
assessment. Acta Radiol. 53:5–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nishimura R, Osako T, Okumura Y, Hayashi M
and Arima N: Clinical significance of Ki-67 in neoadjuvant
chemotherapy for primary breast cancer as a predictor for
chemosensitivity and for prognosis. Breast Cancer. 17:269–275.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bukholm IR, Bukholm G, Holm R and Nesland
JM: Association between histology grade, expression of HsMCM2, and
cyclin A in human invasive breast carcinomas. J Clin Pathol.
56:368–373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wojnar A, Pula B, Piotrowska A, Jethon A,
Kujawa K, Kobierzycki C, Rys J, Podhorska-Okolow M and Dziegiel P:
Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2
proteins in invasive ductal breast carcinoma. Anticancer Res.
31:3027–3033. 2011.PubMed/NCBI
|
|
6
|
Sankpal NV, Willman MW, Fleming TP,
Mayfield JD and Gillanders WE: Transcriptional repression of
epithelial cell adhesion molecule contributes to p53 control of
breast cancer invasion. Cancer Res. 69:753–757. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chae SW, Sohn JH, Kim DH, Choi YJ, Park
YL, Kim K, Cho YH, Pyo JS and Kim JH: Overexpressions of Cyclin B1,
cdc2, p16 and p53 in human breast cancer: The clinicopathologic
correlations and prognostic implications. Yonsei Med J. 52:445–453.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park H, Chang SK, Kim JY, Lee BM and Shin
HS: Risk factors for distant metastasis as a primary site of
treatment failure in early-stage breast cancer. Chonnam Med J.
50:96–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Penault-Llorca F, André F, Sagan C,
Lacroix-Triki M, Denoux Y, Verriele V, Jacquemier J, Baranzelli MC,
Bibeau F, Antoine M, et al: Ki67 expression and docetaxel efficacy
in patients with estrogen receptor-positive breast cancer. J Clin
Oncol. 27:2809–2815. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lialiaris TS, Kouskoukis A, Georgiou G,
Tripsianis G, Fiska A, Giatromanolaki A, Chrisafi S, Sivridis E,
Vamvakopoulou DN, Soutopoulou DO, et al: Expression of 6 common
antigenic markers in invasive ductal breast carcinoma: Potential
clinical implications. Appl Immunohistochem Mol Morphol.
19:106–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wasielewski M, Elstrodt F, Klijn JG, Berns
EM and Schutte M: Thirteen new p53 gene mutants identified among 41
human breast cancer cell lines. Breast Cancer Res Treat. 99:97–101.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bouchbika Z, Benchakroun N, Taleb A,
Jouhadi H, Tawfiq N, Sahraoui S and Benider A: Association between
overexpression of Her-2 and other clinicopathologic prognostic
factors in breast cancer in Morocco. J Cancer Ther. 3:787–792.
2012. View Article : Google Scholar
|
|
14
|
Qu DW, Liu Y, Wang L, Xiong Y, Zhang CL
and Gao DS: Glial cell line-derived neurotrophic factor promotes
proliferation of neuroglioma cells by up-regulation of cyclins PCNA
and Ki-67. Eur Rev Med Pharmacol Sci. 19:2070–2075. 2015.PubMed/NCBI
|
|
15
|
Masubuchi T, Tada Y, Maruya S, Osamura Y,
Kamata SE, Miura K, Fushimi C, Takahashi H, Kawakita D, Kishimoto
S, et al: Clinicopathological significance of androgen receptor,
HER2, Ki-67 and EGFR expressions in salivary duct carcinoma. Int J
Clin Oncol. 20:35–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alshenawy HA: Evaluation of p16, human
papillomavirus capsid protein L1 and Ki-67 in cervical
intraepithelial lesions: Potential utility in diagnosis and
prognosis. Pathol Res Pract. 210:916–921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mansourian M, Haghjooy-Javanmard S,
Eshraghi A, Vaseghi G, Hayatshahi A and Thomas J: Statins use and
risk of breast cancer recurrence and death: A systematic review and
meta-analysis of observational studies. J Pharm Pharm Sci.
19:72–81. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Di Francesco L, Dovizio M, Trenti A,
Marcantoni E, Moore A, Ogaora P, McCarthy C, Tacconelli S, Bruno A,
Alberti S, et al: Dysregulated post-transcriptional control of
COX-2 gene expression in gestational diabetic endothelial cells. Br
J Pharmacol. 172:4575–4587. 2015. View Article : Google Scholar
|
|
19
|
Kim HN, Kim DH, Kim EH, Lee MH, Kundu JK,
Na HK, Cha YN and Surh YJ: Sulforaphane inhibits phorbol
ester-stimulated IKK-NF-κB signaling and COX-2 expression in human
mammary epithelial cells by targeting NF-κB activating kinase and
ERK. Cancer Lett. 351:41–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
